Adare Biome acted as the seller in this M&A transaction.
The divestment involved assets operating in the Healthcare sector.
The transaction was announced on 11 May 2023 with a reported value of 3200000000.0.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises Thomas H. Lee Partners, Frazier Healthcare Partners and Adare Pharma Solutions on potential sale of Adare Biome to Royal DSM | The Sponsor - The Sponsor
